ArticleCrystal growth & design2026
Modeling Pharmaceutical Batch Cooling Crystallization Processes Using Computational Fluid Dynamics Coupled with a One-Dimensional Population Balance Model.
Article in Crystal growth & design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular, Crystal, and Surface Chemistry ofCrystal growth & design · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The batch cooling crystallization of the α polymorphic form of l-glutamic acid from aqueous solution in a kilo-scale 20 L pharmaceutical batch crystallizer is simulated using a multiphase computational fluid dynamics (CFD) model coupled with a one-dimensional population balance equation (PBE). The predicted three-dimensional spatial and temporal distributions of turbulent kinetic energy, supersaturation, nucleation rate, and solid volume fraction provide a high fidelity and very detailed insights into the interplay between crystallizer hydrodynamics and crystallization process kinetics and their resultant impact upon the resulting crystal size distributions (CSDs). Comparison of the CFD-PBE modeling results with published experimental data (Liang, 2002) demonstrates the model's predictive capability by reproducing the measured final CSDs with an acceptable degree of accuracy. An increase in impeller speed is found to increase both the measured and predicted CSD curves shift toward smaller particles sizes. In terms of the spatial variations of process parameters, the evolution of CSD during the crystallization process reveals significant variation of the evolving CSD at the early stages (between 45 and 40 °C) of the crystallization process, which is relatively invariant in the later stages (between 30 and 20 °C), consistent with the reduction of solution supersaturation within the batch process. The simulation results under different agitation rates reveal that at the higher rates, smaller crystals are produced due to a greater level of turbulence and higher supersaturation at an early stage of the process. Detailed sensitivity analysis on the effect of crystallization kinetics on the predicted CSD emphasizes the need for using reliable kinetic data relevant to the crystallization conditions being simulated.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.